Growth Metrics

OmniAb (OABI) Total Non-Current Liabilities (2021 - 2026)

OmniAb (OABI) reported Total Non-Current Liabilities of $30.9 million for Q1 2026, down 5.06% year-over-year from $32.6 million in Q1 2025, and down 8.52% on a QoQ basis from $33.8 million in Q4 2025.

OmniAb (OABI) has 6 years of Total Non-Current Liabilities data on file, last reported at $30.9 million in Q1 2026.

  • Quarterly Total Non-Current Liabilities fell 5.06% year-over-year to $30.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.9 million (down 5.06% YoY) and the FY2025 annual result came in at $33.8 million, down 10.69% from the prior year.
  • Total Non-Current Liabilities retreated to $30.9 million in Q1 2026 per OABI's latest filing, from $33.8 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $79.8 million in Q4 2022 and bottomed at $30.9 million in Q1 2026.
  • The 5-year median for Total Non-Current Liabilities is $40.8 million (2024), against an average of $48.2 million.
  • The widest annual swing landed in 2022, when Total Non-Current Liabilities gained 22.13%; it then slumped 38.44% in 2024.
  • Tracing OABI's Total Non-Current Liabilities over 5 years: stood at $79.8 million in 2022, then slipped by 28.02% to $57.4 million in 2023, then tumbled by 34.09% to $37.9 million in 2024, then decreased by 10.69% to $33.8 million in 2025, then declined by 8.52% to $30.9 million in 2026.
  • Per Business Quant, the three latest OABI Total Non-Current Liabilities figures stand at $30.9 million (Q1 2026), $33.8 million (Q4 2025), and $31.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 11.03 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 42,980.09
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 95.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 110.28 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 5.87 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 7.32 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 4.05 Bn
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 30.93 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 30.93 Mn
Dec 31, 2025 33.81 Mn
Sep 30, 2025 31.73 Mn
Jun 30, 2025 33.53 Mn
Mar 31, 2025 32.58 Mn
Dec 31, 2024 37.85 Mn
Sep 30, 2024 39.77 Mn
Jun 30, 2024 41.89 Mn
Mar 31, 2024 51.13 Mn
Dec 31, 2023 57.44 Mn
Sep 30, 2023 63.64 Mn
Jun 30, 2023 68.05 Mn
Mar 31, 2023 72.20 Mn
Dec 31, 2022 79.79 Mn
Dec 31, 2021 65.33 Mn